1/12
07:17 am
onc
BeOne Medicines (NASDAQ:ONC) was upgraded by analysts at Sanford C. Bernstein to an "outperform" rating.
Low
Report
BeOne Medicines (NASDAQ:ONC) was upgraded by analysts at Sanford C. Bernstein to an "outperform" rating.
1/12
05:52 am
onc
BeOne Medicines upgraded to Outperform from Market Perform at Bernstein
Low
Report
BeOne Medicines upgraded to Outperform from Market Perform at Bernstein
1/12
05:52 am
onc
BeOne Medicines upgraded to Outperform from Market Perform at Bernstein
Low
Report
BeOne Medicines upgraded to Outperform from Market Perform at Bernstein
1/8
08:42 am
onc
BeOne Medicines (NASDAQ:ONC) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
Medium
Report
BeOne Medicines (NASDAQ:ONC) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
1/8
08:42 am
onc
BeOne Medicines (NASDAQ:ONC) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
Medium
Report
BeOne Medicines (NASDAQ:ONC) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
12/17
01:07 pm
onc
BeOne Medicines (NASDAQ:ONC) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.
Low
Report
BeOne Medicines (NASDAQ:ONC) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.
12/17
01:07 pm
onc
BeOne Medicines (NASDAQ:ONC) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.
Low
Report
BeOne Medicines (NASDAQ:ONC) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.
11/18
10:27 am
onc
Rating for ONC
Low
Report
Rating for ONC
11/18
10:27 am
onc
Rating for ONC
Low
Report
Rating for ONC
11/10
04:29 pm
onc
Rating for ONC
Medium
Report
Rating for ONC
11/10
04:29 pm
onc
Rating for ONC
Medium
Report
Rating for ONC
11/7
01:16 pm
onc
Rating for ONC
Low
Report
Rating for ONC
11/7
01:16 pm
onc
Rating for ONC
Low
Report
Rating for ONC